Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1618
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16458614 | Carrier Nanoparticles And Related Compositions, Methods And Systems | Final Rejection | California Institute Of Technology |
| 17863066 | HYBRID NANOPARTICLES COMPRISING MANGANESE OXIDE AND HIGHLY REDUCED GRAPHENE OXIDE FOR THERANOSTIC APPLICATIONS | Non-Final OA | King Saud University |
| 17012614 | MAGNETIC IMMUNO-PARTICLE AND USE THEREOF | Final Rejection | UNIST(ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) |
| 17302143 | METHODS AND COMPOSITIONS FOR PROTECTION OF CELLS AND TISSUES FROM COMPUTED TOMOGRAPHY RADIATION | Final Rejection | The University of Chicago |
| 17769892 | TARGET DELIVERY OF NON-BIOLOGICS THROUGH NANOTECHNOLOGY FOR TISSUE REPAIR | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17739803 | SYSTEMS, METHODS, AND BIOMATERIALS FOR RADIATION THERAPY | Non-Final OA | The Brigham and Women's Hospital, Inc. |
| 18402910 | INHIBITORS OF THE IRE-1/XBP-1 PATHWAY AND METHODS OF USING THEREOF | Final Rejection | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 18349851 | FLUORESCENT COMPOUND COMPRISING A FLUOROPHORE CONJUGATED TO A pH-TRIGGERED POLYPEPTIDE | Non-Final OA | YALE UNIVERSITY |
| 17749902 | MESOSCALE NANOPARTICLES FOR SELECTIVE TARGETING TO THE KIDNEY AND METHODS OF THEIR THERAPEUTIC USE | Non-Final OA | Research Foundation of the City University of New York |
| 18654606 | NANOPARTICLES COMPRISING PEPTIDES INCLUDING AN N-TERMINAL LINKER | Non-Final OA | Topas Therapeutics GmbH |
| 17440067 | PEPTIDE-INDUCED NK CELL ACTIVATION | Non-Final OA | University of Southampton |
| 18647137 | STEM CELL DERIVED PANCREATIC ISLET DIFFERENTIATION | Non-Final OA | Vertex Pharmaceuticals Incorporated |
| 18530122 | LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE,PREPARATION METHOD THEREFOR, AND USES THEREOF | Non-Final OA | Beijing Inno Medicine Co., Ltd. |
| 17610892 | SENSORS AND METHODS USING ELECTROCHEMILUMINESCENCE OF METAL NANOCLUSTERS | Non-Final OA | Georgia State University Research Foundation, Inc. |
| 18270118 | IRON OXIDE MAGNETIC PARTICLES | Non-Final OA | ZTI BIOSCIENCES CO., LTD. |
| 18269585 | IRON OXIDE MAGNETIC PARTICLES | Non-Final OA | ZTI BIOSCIENCES CO.,LTD. |
| 17757786 | uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY | Final Rejection | RIGSHOSPITALET |
| 18255607 | MARKER FOR USE IN IDENTIFYING OR PREDICTING ANGIOGENESIS | Non-Final OA | NOVAI LTD |
| 17613580 | ANTI-GLYPICAN-3 ANTIBODIES AND USES THEREOF | Non-Final OA | Memorial Sloan Kettering Cancer Center |
| 17326995 | ANTI-VIRUS AGENT AND METHOD FOR TREATMENT OF VIRAL INFECTION | Non-Final OA | RECCE PHARMACEUTICALS LTD |
| 17791028 | COMPANION DIAGNOSIS BIOMARKER COMPOSITION AND COMPANION DIAGNOSIS KIT CONTAINING SAME | Non-Final OA | INNOBATION BIO CO., LTD. |
| 17782940 | METHODS, SYSTEMS, AND COMPOSITIONS FOR ACHIEVING A HEALTHY INTRAOCULAR PRESSURE FOLLOWING COMBINED GLAUCOMA FILTRATION SURGERY AND CATARACT EXTRACTION | Non-Final OA | QSA Global Inc. |
| 17773485 | DESIGN AND CHARACTERIZATION OF MULTILAYERED STRUCTURES FOR SUPPORT OF LIPID BILAYERS | Non-Final OA | THE TRUSTEES OF WHEATON COLLEGE |
| 17286946 | DUAL-ROUTE ADMINISTRATION OF COMPOSITION FOR IMPROVED PROTECTION OF PLANTS AGAINST PATHOGENS | Final Rejection | GRACE BREEDING LTD. |
| 17296166 | MICRO-NANO STRUCTURE FORMED BY SELF-ASSEMBLING ORGANIC SMALL MOLECULE COMPOUND AND USE THEREOF | Non-Final OA | Qingdao University of Science and Technology |
| 17413517 | METHOD OF PRODUCING POLY(ALKYL CYANOACRYLATE) BASED NANO/MICROFIBERS AND USES THEREOF | Final Rejection | WIWEX GmbH |
| 17229013 | Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor | Non-Final OA | KENSINGTON CLENE 2024 LLC |
| 17253550 | MACROCYCLE CONJUGATES | Final Rejection | LUMIPHORE, INC. |
| 16089758 | LIGHT-EMITTING NANOPARTICLES, CELL DETECTION METHOD USING SAME, ANIMAL TREATMENT METHOD, MEDICAL DEVICE, CELL VISUALIZATION METHOD, AND METHOD FOR REDUCING INJURY TO CELL | Final Rejection | National Institute of Technology |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy